Insert | Editorially independent content supported by advertising from Genentech
2021 Retina Pipeline: A View Into Ongoing Innovation [Interactive]
Knowing where everything stands helps prepare you for the next era.
Insert | Editorially independent content supported by advertising from Genentech
Knowing where everything stands helps prepare you for the next era.
Watch as Peter K. Kaiser, MD, explains the poster and follow along with graphics below.
In designing the second edition of Retina Today’s pipeline poster for wet and dry age-related macular degeneration (AMD), we focused largely on expanding the schematic used to illustrate the complement system. For many of us, the complement system is a relic of our medical training, something to be dusted off when conversation turns down a more erudite path. In the coming years, however, the complement system may well be key to unlocking therapies for dry AMD that could affect millions of patients.
In a way, we have attempted the impossible by illustrating the complement pathway. An artistic representation of a cascade that takes place on the cellular surface must (by virtue of graphic limitations) be depicted away from that surface, giving the impression that the events occur in some vacuous space between cells. They do not. Still, we know that our readers understand this and are even more certain that a detailed map of the complement system’s steps is more important than a strict biologic geography lesson.
This edition of this poster consists of more than just cosmetic changes. We eliminated failed drugs, added new therapeutic candidates, and enlarged the complement system illustration to include new therapeutic targets.
Meetings might be paused for the foreseeable future, but that doesn’t mean that education has stopped. Turn to this poster (and its digital interactive facsimile, found at bit.ly/retina-pipeline) to keep yourself sharp.
And remember: this poster is for you. Tear it out. Mark it up. Send us suggestions for how to improve it. We’re already thinking about ways to develop it for next year’s edition, and we need to hear from our audience about what works and what doesn’t.
+ Read More
Continue to scroll to see the each pathway displayed in the diagram to the left.
Neuroprotection
Repair mitochondrial dysfunction/oxidative stress:
Reduce toxic by-product accumulation
Prevents Amyloid Aβ oligomer assembly:
Reduce DHA peroxidation:
Visual cycle modulation
Stem Cells
Other approaches
Inflammasome Inhibition:
Matrix Modulation:
HtrA1 inhibitor:
Suppress inflammation
Targeting the Complement Cascade:
C1q Inhibition
C3 Convertase Inhibition
C3 Convertase Inhibition
C5 Convertase Inhibition
C5 Convertase Inhibition
MAC Inhibition by sCD59
Complement Factor D Inhibition
Complement Factor B Inhibition
Complement Factor H Therapy
Complement Factor I Therapy
Blocks MASP-2
MASP-3
Blocks C3 Osponization
sCR1 Inhibition/Anti-VEGF
Blocks M1 Transcriptome Expression
Enhances CFH Binding to C3b
Blocks C3b/Anti-VEGF
View the full size poster from the November/December issue.